Therefore, in addition to Ewing sarcoma, targeted inhibition of OTUD7A may be relevant for other cancers dependent on FLI1 for proliferation, such as leukemia and kidney cancer (Figure S20G, Supporting Information). This evidence concerns the gene FLI1 and cancer.